mRNA Vaccines for COVID-19
Recently, a rush of interim analyses from pharmaceutical companies Moderna and Pfizer/BioNTech has spurred optimism that a novel type of vaccine made from messenger RNA, known as mRNA, can offer high levels of protection by preventing COVID-19 among people who are vaccinated.
- Moderna’s new mRNA vaccine is almost 94.5% effective in large-scale trials. Similarly, Pfizer’s vaccine has also shown an efficacy of around 95%.
mRNA Vaccine Function
- mRNA vaccines are a new type of vaccine to protect against infectious diseases. To trigger an immune response, a mRNA vaccine teaches our cells how to make a protein or even just a portion ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 IISc Develops Light-Charged Supercapacitor Technology
- 2 New Nanomaterial Tackles Heavy Metal Contamination
- 3 INCOIS Unveils ‘Integrated Ocean Energy Atlas’
- 4 IISc Develops Brain-Like AI Computing Platform
- 5 India Launches Three Indigenous Supercomputers
- 6 Indigenous Light Tank 'Zorawar'
- 7 ABHED: India’s Cutting-Edge Bulletproof Jacket
- 8 India’s Venus Orbiter Mission
- 9 Thermal Imaging Operations by ISRO’s EOS-08 Satellite
- 10 2024 PT5: A Temporary “Mini-Moon” of Earth
- 1 Hayabusa 2: Samples from Asteroid Ryugu
- 2 Change-5 Lunar Mission
- 3 Sentinel-6A Satellite
- 4 Ariel Space Mission
- 5 Desalination: A Panacea for Water Scarcity
- 6 QRSAM Tested Successfully
- 7 Sea Guardian Drones for Indian Navy
- 8 Varunastra
- 9 43 New Chinese Apps Banned in India
- 10 Conference on Criminal Finance and Cryptography
